• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种用于获得基于RNA的适配体的自动化体外筛选方案:鉴定一种生物稳定的P物质拮抗剂。

Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist.

作者信息

Eulberg Dirk, Buchner Klaus, Maasch Christian, Klussmann Sven

机构信息

NOXXON Pharma AG, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany.

出版信息

Nucleic Acids Res. 2005 Mar 3;33(4):e45. doi: 10.1093/nar/gni044.

DOI:10.1093/nar/gni044
PMID:15745995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC552970/
Abstract

We have developed an automated SELEX (Systematic Evolution of Ligands by EXponential Enrichment) process that allows the execution of in vitro selection cycles without any direct manual intervention steps. The automated selection protocol is designed to provide for high flexibility and versatility in terms of choice of buffers and reagents as well as stringency of selection conditions. Employing the automated SELEX process, we have identified RNA aptamers to the mirror-image configuration (d-peptide) of substance P. The peptide substance P belongs to the tachykinin family and exerts various biologically important functions, such as peripheral vasodilation, smooth muscle contraction and pain transmission. The aptamer that was identified most frequently was truncated to the 44mer SUP-A-004. The mirror-image configuration of SUP-A-004, the so-called Spiegelmer, has been shown to bind to naturally occurring l-substance P displaying a K(d) of 40 nM and to inhibit (IC50 of 45 nM) l-substance P-mediated Ca2+ release in a cell culture assay.

摘要

我们开发了一种自动化的指数富集配体系统进化(SELEX)方法,该方法无需任何直接的人工干预步骤即可进行体外筛选循环。自动化筛选方案旨在在缓冲液和试剂的选择以及筛选条件的严格性方面提供高度的灵活性和通用性。利用自动化SELEX方法,我们鉴定出了针对P物质镜像构型(d-肽)的RNA适配体。肽类物质P属于速激肽家族,具有多种重要的生物学功能,如外周血管舒张、平滑肌收缩和疼痛传递。最常鉴定出的适配体被截短为44聚体SUP-A-004。SUP-A-004的镜像构型,即所谓的镜像体,已被证明能与天然存在的l-物质P结合,解离常数(K(d))为40 nM,并在细胞培养试验中抑制(半数抑制浓度(IC50)为45 nM)l-物质P介导的Ca2+释放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/b0e402be8e27/gni044f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/bbe1040ed21e/gni044f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/25c0e158c2f9/gni044f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/f94a1f99cd7b/gni044f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/06b81a2b8d04/gni044f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/b0e402be8e27/gni044f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/bbe1040ed21e/gni044f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/25c0e158c2f9/gni044f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/f94a1f99cd7b/gni044f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/06b81a2b8d04/gni044f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ae/552970/b0e402be8e27/gni044f5.jpg

相似文献

1
Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist.开发一种用于获得基于RNA的适配体的自动化体外筛选方案:鉴定一种生物稳定的P物质拮抗剂。
Nucleic Acids Res. 2005 Mar 3;33(4):e45. doi: 10.1093/nar/gni044.
2
In vitro selection using a dual RNA library that allows primerless selection.使用允许无引物选择的双RNA文库进行体外筛选。
Nucleic Acids Res. 2006 Jul 19;34(12):e86. doi: 10.1093/nar/gkl463.
3
Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.针对细胞表面展示的重组转化生长因子-βⅢ型受体筛选RNA适配体。
Biochimie. 2006 Jul;88(7):897-904. doi: 10.1016/j.biochi.2006.02.004. Epub 2006 Mar 6.
4
Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers.结合指数富集的配体系统进化(SELEX)和酵母三杂交系统用于RNA适体的体内筛选和分类。
RNA. 2007 Apr;13(4):614-22. doi: 10.1261/rna.334307. Epub 2007 Feb 5.
5
Effects of single nucleotide changes on the binding and activity of RNA aptamers to human papillomavirus 16 E7 oncoprotein.单核苷酸突变对 RNA 适体与人乳头瘤病毒 16 E7 癌蛋白结合和活性的影响。
Biochem Biophys Res Commun. 2011 Feb 18;405(3):417-21. doi: 10.1016/j.bbrc.2011.01.044. Epub 2011 Jan 14.
6
Effective isolation of RNA aptamer through suppression of PCR bias.通过抑制PCR偏差有效分离RNA适配体。
Biochem Biophys Res Commun. 2009 Aug 14;386(1):223-6. doi: 10.1016/j.bbrc.2009.06.013. Epub 2009 Jun 9.
7
RNA aptamers to a protease, subtilisin.针对蛋白酶枯草杆菌蛋白酶的RNA适配体。
Nucleic Acids Symp Ser. 1997(37):249-50.
8
RNA aptamers specific for bovine thrombin.对牛凝血酶具有特异性的RNA适配体。
J Mol Recognit. 2003 Jan-Feb;16(1):23-7. doi: 10.1002/jmr.604.
9
In vitro selection of RNA ligands to substance P.针对P物质的RNA配体的体外筛选。
Biochemistry. 1995 Apr 25;34(16):5651-9. doi: 10.1021/bi00016a041.
10
SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.SELEX——一种用于生成高亲和力核酸配体的革命性方法。
Biomol Eng. 2007 Oct;24(4):381-403. doi: 10.1016/j.bioeng.2007.06.001. Epub 2007 Jun 16.

引用本文的文献

1
Emerging Biohybrids of Aptamer-Based Nano-Biosensing Technologies for Effective Early Cancer Detection.基于适体的纳米生物传感技术的新兴生物杂交体用于有效的早期癌症检测。
Mol Diagn Ther. 2024 Jul;28(4):425-453. doi: 10.1007/s40291-024-00717-x. Epub 2024 May 22.
2
Aptamers in neuro-oncology: An emerging therapeutic modality.神经肿瘤学中的适体:一种新兴的治疗模式。
Neuro Oncol. 2024 Jan 5;26(1):38-54. doi: 10.1093/neuonc/noad156.
3
Applications in Which Aptamers Are Needed or Wanted in Diagnostics and Therapeutics.在诊断和治疗中需要或希望使用适体的应用。

本文引用的文献

1
Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX.通过一种新方法——定制SELEX快速鉴定出与偏头痛相关的降钙素基因相关肽的短生物活性 Spiegelmers
Nucleic Acids Res. 2003 Nov 1;31(21):e130. doi: 10.1093/nar/gng130.
2
Mfold web server for nucleic acid folding and hybridization prediction.用于核酸折叠和杂交预测的Mfold网络服务器。
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15. doi: 10.1093/nar/gkg595.
3
Characterization of the endokinins: human tachykinins with cardiovascular activity.
Pharmaceuticals (Basel). 2022 Jun 1;15(6):693. doi: 10.3390/ph15060693.
4
Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.病毒学中的适配体——诊断与治疗最新进展的综合综述
Pharmaceutics. 2021 Oct 9;13(10):1646. doi: 10.3390/pharmaceutics13101646.
5
In Vivo Production of RNA Aptamers and Nanoparticles: Problems and Prospects.在体产生 RNA 适体和纳米颗粒:问题与展望。
Molecules. 2021 Mar 6;26(5):1422. doi: 10.3390/molecules26051422.
6
Advances and Challenges in Small-Molecule DNA Aptamer Isolation, Characterization, and Sensor Development.小分子 DNA 适体的分离、鉴定和传感器开发的进展与挑战。
Angew Chem Int Ed Engl. 2021 Jul 26;60(31):16800-16823. doi: 10.1002/anie.202008663. Epub 2021 Feb 9.
7
Inside the Black Box: What Makes SELEX Better?黑箱之内:SELEX 缘何更优?
Molecules. 2019 Oct 7;24(19):3598. doi: 10.3390/molecules24193598.
8
Robotic assisted generation of 2'-deoxy-2'-fluoro-modifed RNA aptamers - High performance enabling strategies in aptamer selection.机器人辅助生成 2'-脱氧-2'-氟修饰的 RNA 适体 - 适体选择中的高性能实现策略。
Methods. 2019 May 15;161:3-9. doi: 10.1016/j.ymeth.2019.05.022. Epub 2019 May 30.
9
Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.核酸适体:在医学成像、纳米技术、神经科学和药物输送中的新兴应用。
Int J Mol Sci. 2017 Nov 16;18(11):2430. doi: 10.3390/ijms18112430.
10
Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.适体及其在癌症治疗与诊断中的重要作用。
Biomedicines. 2015 Sep 1;3(3):248-269. doi: 10.3390/biomedicines3030248.
内激肽的特性:具有心血管活性的人速激肽
Proc Natl Acad Sci U S A. 2003 May 13;100(10):6245-50. doi: 10.1073/pnas.0931458100. Epub 2003 Apr 25.
4
Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.针对体外翻译的蛋白质靶标的适配体自动筛选:从基因到适配体。
Nucleic Acids Res. 2002 Oct 15;30(20):e108. doi: 10.1093/nar/gnf107.
5
Automated acquisition of aptamer sequences.适配体序列的自动获取。
Comb Chem High Throughput Screen. 2002 Jun;5(4):289-99. doi: 10.2174/1386207023330291.
6
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family.速激肽家族新成员——血激肽1的药理学特性
Life Sci. 2002 Jun 14;71(4):363-70. doi: 10.1016/s0024-3205(02)01682-x.
7
The tachykinin peptide family.速激肽肽家族。
Pharmacol Rev. 2002 Jun;54(2):285-322. doi: 10.1124/pr.54.2.285.
8
Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.新型哺乳动物速激肽——血激肽1的药理学特性
Br J Pharmacol. 2002 Jan;135(1):266-74. doi: 10.1038/sj.bjp.0704443.
9
Automated selection of anti-protein aptamers.抗蛋白质适体的自动筛选
Bioorg Med Chem. 2001 Oct;9(10):2525-31. doi: 10.1016/s0968-0896(01)00028-1.
10
Substance p.P物质
Int J Biochem Cell Biol. 2001 Jun;33(6):555-76. doi: 10.1016/s1357-2725(01)00031-0.